Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

So, while you should always follow the fundamentals of healthy living – like exercising and eating a balanced diet – ...

Piper Sandler initiated coverage on Abbott Laboratories (NYSE: ABT) with an "overweight" rating and a price target of $131 ...

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

Recommended Reading Senseonics receives FDA clearance for one-year CGM Some people who use a Freestyle Libre 3 glucose sensor are facing delays getting their prescriptions filled. Abbott ...

Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage of its revenues comes from outside the ...

A parenting expert has given five top tips to help parents adjust to a quieter household as millions of students prepare to ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Diane Abbott has reignited her row with Sir Keir Starmer over anti-Semitism by suggesting “allies” of the Prime Minister are treated differently from his enemies when such accusations are made.

Gerry Baker is Editor at Large of The Wall Street Journal. His weekly column for the editorial page, “Free Expression,” appears in The Wall Street Journal each Tuesday. Mr. Baker is also host ...